# SIROLIMUS
> **ANDA208691** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2020-10-16
## Drug
- **FDA Application Number:** ANDA208691
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SIROLIMUS
- **Generic name:** SIROLIMUS
- **Active ingredients:** SIROLIMUS
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GLENMARK PHARMS LTD
- **Manufacturer:** NORTHSTAR RX LLC
- **First approval:** 2020-10-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208691)
---
*MORVS · CC0 1.0*